Ishikawa Prefectural Central Hospital
In research, Ishikawa Prefectural Central Hospital stands highest in Medicine (#8,959 of 10,443 worldwide) and Health Sciences (#10,721 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Surgery and Medicine — Surgery is 10.6× its share of world research.
- World rank, 2022–2025
- #22,126 of 28,054 · #32,611 all time
- Rank in Japan
- #696 of 1,070
- Research works
- 745 ▲ 29% vs 2013–17
- Citations
- 7.1k 9.6 per fractional work
- Top-10% rate
- 8.5% record average 16.5%
- Open access
- 51% world 28%
What is Ishikawa Prefectural Central Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #8,959 of 10,443 | 7.7% | 101 | #12223 | |
| Health SciencesDomain | #10,721 of 11,982 | 7.9% | 104 | #15312 |
Each strip is that field’s whole ranked pool, with the notch where Ishikawa Prefectural Central Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Ishikawa Prefectural Central Hospital specialise in?
Where its research is concentrated relative to its size: Surgery takes 10.6× the share of its output that it takes of world research.
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.6×. Every wedge is a field page.
- Medicine 4.6×
- Veterinary 2.1×
- Immunology and Microbiology 1.3×
- Biochemistry, Genetics and Molecular Biology 0.8×
- Dentistry 0.7×
- Health Professions 0.5×
- Nursing 0.5×
- Pharmacology, Toxicology and Pharmaceutics 0.4×
- Neuroscience 0.4×
- Psychology 0.3×
- Economics, Econometrics and Finance 0.1×
- Physics and Astronomy 0.1×
- Engineering 0.1×
- Environmental Science 0.1×
- Business, Management and Accounting 0.0×
- Agricultural and Biological Sciences 0.0×
Who are the top researchers at Ishikawa Prefectural Central Hospital?
Ranked on the composite score, Tetsuji Yamada, Masaru Miyata and Kunihiro Tsuji lead among researchers whose main affiliation is Ishikawa Prefectural Central Hospital.
- 1 Tetsuji Yamada Japan · #36,148 worldwide 572 citations · 73 works
- 2 Masaru Miyata Japan · #478,278 worldwide 16 citations · 26 works
- 3 Kunihiro Tsuji Japan · #546,828 worldwide 49 citations · 33 works
- 4 Hiroshi Kurumaya Japan · #549,986 worldwide 56 citations · 39 works
- 5 Takio Ohka Japan · #557,966 worldwide 19 citations · 21 works
- 6 Yoshio Tsunezuka Japan · #594,520 worldwide 48 citations · 30 works
- 7 Masaaki NAKAGAWA Japan · #638,622 worldwide 11 citations · 19 works
- 8 Masahiro Kitabayashi Japan · #762,208 worldwide 2 citations · 23 works
- 9 Shinichi Kadoya Japan · #847,025 worldwide 14 citations · 26 works
- 10 Hirotaka Kitamura Japan · #892,468 worldwide 8 citations · 21 works
Which keywords describe research at Ishikawa Prefectural Central Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Molecular Characterization, Endoscopic Resection, Gastric Cancer, Adjuvant Therapy, Survival Analysis and Neoadjuvant Chemotherapy.
- Chemoradiation
- Clinical Management
- Preoperative Chemoradiotherapy
- Surgery
- Guidelines
- Management
- Complications
- Tumor Microenvironment
- Surgical Management
- Cholesterol-lowering
- C-Reactive Protein
- Immunotherapy
- Genetic Variants
- Inflammation
- Clinical Trials
- Lymph Node Dissection
- Survival Analysis
- Gastric Cancer
- Molecular Characterization
- Epidemiology
- Chemotherapy
- Clinical Practice Guidelines
- Endoscopic Resection
- Adjuvant Therapy
- Neoadjuvant Chemotherapy
- Metastatic Gastric Cancer
- Statins
- Diagnosis
- Genetic Mutations
- Neoadjuvant Therapy
- Cardiovascular Disease Prevention
- LDL Cholesterol
- Treatment
- Prognostic Factors
- Atherosclerosis
- Cholesterol
- Metabolic Syndrome
- Obesity
- Prevention
- Echocardiography
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy16▲ 20×19 topics
- Epidemiology14▲ 3.0×52 topics
- Clinical Practice Guidelines11▲ 18×11 topics
- Molecular Characterization10▲ 51×4 topics
- Endoscopic Resection10▲ 90×2 topics
- Gastric Cancer10▲ 75×3 topics
- Adjuvant Therapy10▲ 67×2 topics
- Survival Analysis9▲ 30×5 topics
- Neoadjuvant Chemotherapy9▲ 91×2 topics
- Lymph Node Dissection8▲ 123×1 topic
- Metastatic Gastric Cancer8▲ 123×1 topic
- Clinical Trials8▲ 11×6 topics
- Statins7▲ 83×2 topics
- Inflammation6▲ 2.7×22 topics
- Diagnosis6▲ 6.0×25 topics
- Genetic Variants6▲ 32×4 topics
- Genetic Mutations6▲ 12×10 topics
- Immunotherapy6▲ 6.9×14 topics
- Neoadjuvant Therapy6▲ 21×5 topics
- C-Reactive Protein6▲ 65×2 topics
- Cardiovascular Disease Prevention6▲ 55×2 topics
- Cholesterol-lowering5▲ 104×1 topic
- LDL Cholesterol5▲ 136×1 topic
- Surgical Management5▲ 11×11 topics
- Treatment5▲ 3.7×18 topics
- Tumor Microenvironment5▲ 9.3×6 topics
- Prognostic Factors5▲ 9.3×12 topics
- Complications4▲ 7.7×11 topics
- Atherosclerosis4▲ 13×6 topics
- Management4▲ 4.4×16 topics
- Cholesterol4▲ 24×3 topics
- Guidelines4▲ 7.2×10 topics
- Metabolic Syndrome4▲ 4.0×8 topics
- Surgery4▲ 9.2×6 topics
- Obesity4▲ 4.1×6 topics
- Preoperative Chemoradiotherapy3▲ 32×2 topics
- Prevention3▲ 5.8×7 topics
- Clinical Management3▲ 13×6 topics
- Echocardiography3▲ 8.4×6 topics
- Chemoradiation2▲ 34×2 topics
Which research topics does Ishikawa Prefectural Central Hospital publish most on?
By volume in 2022–2025: Gastric Cancer Management and Outcomes, Lipoproteins and Cardiovascular Health, Esophageal and GI Pathology and Gastrointestinal Tumor Research and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 8 works
- 2 Lipoproteins and Cardiovascular Health Surgery 5 works
- 3 Esophageal and GI Pathology Surgery 2 works
- 4 Gastrointestinal Tumor Research and Treatment Gastroenterology 2 works
- 5 Esophageal Cancer Research and Treatment Surgery 2 works
- 6 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 7 Cancer, Lipids, and Metabolism Cancer Research 2 works
- 8 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 2 works
- 9 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
- 10 Pancreatic and Hepatic Oncology Research Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Ishikawa Prefectural Central Hospital's research output changed?
Output in 2018–2022 was 29% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Kanazawa
- Kanazawa University
- Kanazawa Medical University
- Hokuriku University
- Kanazawa University Hospital
- Kanazawa Hospital
- Mirai Hospital
- Kanazawa Medical Center
- Asanogawa General Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.